Palm Air Civic Ass'n v. Syncor International Corp.Palm Air Civic Ass'n v. Syncor International Corp.
On December 6,1994 Palm Air Civic Association (PACA) filed for injunctive relief and a judgment declaring that the radiopharmacy operated by Syncor International Corporation was prohibited by the Comprehensive Zoning Ordinance (CZO). PACA claimed that the City’s permit was void under the CZO, and the City and the Department of Safety and Permits (DSP) Zoning Administrator (Paul May) failed to enforce the CZO and its regulations. PACA also sought to enjoin Syncor from operating the radiophar-macy or nuclear pharmacy at 9501 Airline Highway which was zoned C-l, general commercial district. Syncor, the City of New Orleans, and Paul May filed exceptions of prematurity and prescription. The trial court maintained the exceptions of prescription and overruled the exceptions of prematurity as moot.
Palm-Air Subdivision is near the Orleans/Jefferson Parish line and bordered by Airline Highway (originally known as Holly-grove). PACA is an association of citizens who live in the subdivision. The radiophar-macy is located across the street from the nearest row of Palm-Air residents. On September 28, 1993 Paul |2May issued a building permit to Syncor for 9501 Airline Highway. The permit was for “New construction of Radio Pharmacy....” Under specific occupancy was listed “office bldg.” The operation of a radiopharmacy involves the packaging of doses and distribution of radiopharmaceuticals to hospitals and clinics. PACA alleges that its members did not learn of Syncor’s intended use until March or April, 1994.
Due to PACA’s concerns the New Orleans City Council on April 21, 1994 unanimously passed a resolution declaring that DSP should issue a stop work order to allow the City Attorney’s Office to issue a legal opinion. DSP did not issue the stop order and the building was completed in July, 1994. A certificate of use and occupancy for the ra-diopharmacy was issued August 12, 1994. On August 25, 1994 Syncor began operating a radiopharmacy.
The City Attorney’s Office issued two opinions to the City Council. An opinion dated May 6, 1994 concluded that DSP’s Director’s determination that a radiopharmacy might be located in a C-l district was “questionable although not necessarily unreasonable.” It noted that radiopharmacy and pharmacy are not listed as permitted uses in a C-l district,
The only issue is prescription. PACA argues that its petition was timely under La. R.S. 9:5625 A which provides that “[a]ll actions ... brought ... to require enforcement of and compliance with any zoning restriction, building restriction or subdivision regulation, ... based upon the violation ... of such restriction or regulation, must be brought within two years from the first act constituting the commission of the violation....”
The defendants argue that the applicable prescriptive period is in La.R.S. 33:4727, the CZO, and Board of Zoning Adjustments (BZA) rules. La.R.S. 33:4727(C)(2)(a) and CZO art. 13, § 4 provide that a person aggrieved by a DSP decision may appeal that decision to the BZA and such an appeal shall be taken within a reasonable time as provided by BZA’s rules. The BZA Rules of Procedure and Policy art. II, § 6 provides that every appeal “shall be taken within forty-five (45) days” from the date of a decision or determination by the Director of DSP.
The defendants mistakenly rely on Abaunza v. Bolian,
This Court’s subsequent opinions involving similar prescription arguments clearly hold that La.R.S. 9:5625 is not superseded by the zoning ordinance. Redfearn v. Creppel,
In Brennan,
Additionally, 1993 La.Acts, No. 1025, § 1 added Subsection E to La.R.S. 9:5625: “The provisions of this Section shall supersede any other provisions of law inconsistent herewith.”
CZO art. 5, § 12, general commercial district, declares that the purpose of a C-1 district is to provide locations for “a variety of commercial and miscellaneous service activities.” Uses permitted in a C-1 district also include | (¡those allowed in B-1 or B-2 districts including general business or professional offices and general retail and service establishments. In its petition PACA alleged that Syncor’s radiopharmacy’s location in a C-1 general commercial district violated CZO art. 4, §§ 1 and 5, which provide that no building or land shall be used and no building erected “unless in conformity with the regulations set forth in this Ordinance” and “uses not specifically listed [for the district] are prohibited” unless the contrary is clear from the context of the lists or other regulations. Radiopharmacy or nuclear pharmacy is not listed in CZO art. 5, § 12, general commercial district, and is not listed as a permitted use anywhere in the CZO. PACA claimed that the location of Syncor’s radiopharmacy in a C-l general commercial district violated the CZO because radiopharmacy was not listed as a permitted use in CZO art. 5, § 12 and it is not clear whether a radiopharmacy is a permitted use in a C-l district. PACA also alleged that the use permit issued by DSP was void under CZO art. 15, § 2.2 because the proposed use of the building as a radio-pharmacy did not conform to the CZO requirements.
PACA filed its petition for declaratory and injunctive relief claiming a violation of the CZO within two years of the first act which allegedly constituted a violation, the issuance of the building permit on September 28, 1993. The trial court erred by maintaining the exception of prescription prior to trial during which PACA would have an opportunity to prove a violation of law.
The judgment is reversed and the matter remanded for further proceedings.
REVERSED; REMANDED.